Ceredex Value Advisors’s Merck MRK Stock Holding History

Ceredex Value Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.6M	Sell	212,600 -36,009	-14%	-$4.16M	0.8%	33
2025 Q4	$26.2M	Sell	248,609 -59,123	-19%	-$5.55M	0.79%	35
2025 Q3	$25.8M	Buy	+307,732	New	+$25.3M	0.6%	56
2021 Q1	–	Sell	-658,314	Closed	-$51.8M	–	142
2020 Q4	$51.8M	Sell	658,314 -492,398	-43%	-$37.7M	0.66%	59
2020 Q3	$91.8M	Sell	1,150,712 -226,399	-16%	-$17.7M	1.35%	25
2020 Q2	$102M	Buy	+1,377,111	New	+$104M	1.52%	17

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ceredex Value Advisors's MRK Position: Q1 2026 in Review

Ceredex Value Advisors reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $4.16M and leaving 212,600 shares worth $25.6M. The position accounts for 0.8% of the portfolio, ranked #33.

Ceredex Value Advisors first reported a position in MRK in Q2 2020 and has held it in 6 quarters since. The position peaked at $102M in Q2 2020. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Ceredex Value Advisors held 212,600 shares of Merck worth $25.6M as of Q1 2026.
Ceredex Value Advisors sold 36,009 Merck shares in Q1 2026, an estimated $4.16M.
Merck made up 0.8% of Ceredex Value Advisors's portfolio in Q1 2026, its #33 holding.
Ceredex Value Advisors first reported a position in Merck in Q2 2020 and has held it in 6 quarters since.
Ceredex Value Advisors's Merck position peaked at $102M in Q2 2020.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ceredex Value Advisors's 13F filing for Q1 2026, filed 14 May 2026.